SAU:4009

Middle East Healthcare Company · SAU · Healthcare · SAR · FY for 2025

Figures on this page computed 2026-11-08 13:39 UTC

Last close

n/aSAR

Market data

7.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
SAR
- computed
- Computed from the filing for 2025
8.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
9.7%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
-3.2%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
1.36Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
SAR
- computed

Safety is the furthest below its sector's middle: 0.32 against 0.57 on the market's range.

All from 100

lens 2 of 9

Sales

202

2015-12-31 to 2025-12-31100 at the start202

Sales: 100.00 on 2015-12-31 to 202.19 on 2025-12-31, up 102%.

Profit

77.4

2015-12-31 to 2025-12-31100 at the start77.4

Profit: 100.00 on 2015-12-31 to 77.36 on 2025-12-31, down 23%.

Shares in issue

100.0

2015-12-31 to 2025-12-31100 at the start100.0

Shares in issue: 100.00 on 2015-12-31 to 100.00 on 2025-12-31, down 0%.

Sales is at 202, Profit is at 77, Shares in issue is at 100, against 100 in 2015.

Sales is at 202, Profit is at 77, Shares in issue is at 100, against 100 in 2015.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100202
Source
computed
Statement
income
Fiscal year
2025
Reported in
SAR
Profit, where the first year is 10077
Source
computed
Statement
income
Fiscal year
2025
Reported in
SAR
Shares in issue, where the first year is 100100
Source
computed
Statement
income
Fiscal year
2025
Reported in
SAR